 |
 |

Effect of Timolol on the Diurnal Intraocular Pressure in Exfoliation and Primary Open-angle Glaucoma
Anastasios G. P. Konstas, MD, PhD;
Dimitrios A. Mantziris, MD;
Elin A. Cate;
William C. Stewart, MD
Arch Ophthalmol. 1997;115(8):975-979.
Abstract
 |  |
Objective To describe and compare the diurnal intraocular pressure (IOP) variation in patients with exfoliation glaucoma (EXG) and primary open-angle glaucoma (POAG) who were treated with a solution of timolol maleate (0.5%) twice daily.
Design Consecutive Greek patients who were newly diagnosed as having EXG or POAG were prospectively investigated; they underwent 24-hour diurnal IOP measurements first without therapy and then 6 months afterward while they were being treated with timolol maleate (0.5%). After matching for age, 38 pairs of patients with these 2 types of glaucoma were compared.
Results Untreated patients with EXG had significantly higher IOP values for all time points assessed and a greater mean range of IOPs (11.8 mm Hg for EXG vs 7.6 mm Hg for POAG; P .001 ). Following therapy with timolol maleate (0.5%) given twice daily, patients with EXG had higher IOP values for the measurements that were obtained at 6 and 10 AM, 10 PM, and 2 AM, a higher mean range of IOPs (7.0 mm Hg for EXG vs 5.6 mm Hg for POAG; P=.03), and a higher maximum IOP (mean, 24.9 mm Hg for EXG vs 20.9 mm Hg for POAG; P=.003). The reduction of the range of diurnal variation of IOP was more pronounced in patients with EXG than in patients with POAG (40% vs 26%; P=.04). Twenty-two (58%) of 38 patients with EXG and 20 (53%) of 38 patients with POAG had peak IOP values that were found outside office hours. Only 5 (13%) of the patients with EXG exhibited an IOP of 18 mm Hg or less at all time points compared with 12 (32%) of the patients with POAG (P=.05).
Conclusion Despite a greater initial IOP reduction in the patients with EXG treated with timolol, a higher IOP and significant fluctuation in the diurnal curve of IOP during the time in which patients received therapy still characterized EXG from POAG.
Author Affiliations
From the University Department of Ophthalmology, AHEPA Hospital, Thessaloníki, Greece (Drs Konstas and Mantziris), the Pharmaceutical Research Corporation, Charleston, SC (Ms Cate and Dr Stewart), and the Carolina Eye Institute at the University of South Carolina, Columbia (Dr Stewart).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Twenty-four-hour intraocular pressure control with the travoprost/timolol maleate fixed combination compared with travoprost when both are dosed in the evening in primary open-angle glaucoma
Konstas et al.
Br J Ophthalmol 2009;93:481-485.
ABSTRACT
| FULL TEXT
Circadian Variation of Aqueous Dynamics in Young Healthy Adults
Sit et al.
IOVS 2008;49:1473-1479.
ABSTRACT
| FULL TEXT
Quality of diurnal intraocular pressure control in primary open-angle patients treated with latanoprost compared with surgically treated glaucoma patients: a prospective trial
Mansouri et al.
Br J Ophthalmol 2008;92:332-336.
ABSTRACT
| FULL TEXT
Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study
Konstas et al.
Br J Ophthalmol 2007;91:757-760.
ABSTRACT
| FULL TEXT
24-Hour Control With a Latanoprost-Timolol Fixed Combination vs Timolol Alone.
Konstas et al.
Arch Ophthalmol 2006;124:1553-1557.
ABSTRACT
| FULL TEXT
Twenty-four-Hour Control With Latanoprost-Timolol-Fixed Combination Therapy vs Latanoprost Therapy
Konstas et al.
Arch Ophthalmol 2005;123:898-902.
ABSTRACT
| FULL TEXT
|